BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.


Thought Leadership

Transforming Trials

ICON is rethinking the clinical trials process using new approaches, coupled with existing technologies to substantially reduce the risk and cost of clinical drug development.

Adaptive Trials

Insights to help you understand and address the complexities of adaptive trial design and execution. 

Wearables

Understand and successfully address the complexities of implementation of wearable devices in trial design, execution and reporting.

Harnessing Technology to maximise RWE value

Technology innovations can enable faster collection, standardisation, and analysis of real world data assets. Learn how sponsors can take full advantage of these innovations.

MDR and IVDR are Coming - Are you Prepared?

Discover the best methods for mitigating anticipated delays and increased costs in this new regulatory environment.

Cardiovascular Medical Devices

Discover how sponsors can respond to new business risks and opportunities in a value-based payment environment with this white paper. 

ICH GCP (R2)

The upcoming addendum focuses on three key areas; technology validation and certification, risk based quality management systems and increased oversight.

Meeting Evidentiary Needs with Electronic Health Records

Read this white paper to learn how you can leverage these systems for maximum benefit in observational studies and pragmatic clinical trials. 

Transforming Medical Device Development

ICON whitepaper which deconstructs the critical challenges to achieving mandates for cost efficiency and productivity.

Strategic Alliances

ICON sponsored research outlines partnership strategies to optimise clinical drug development.

Bring Your Own Device (BYOD)

BYOD promises greater patient-centricity and will make study management less complex.

Global Outcomes Benchmarking

ICON and ICHOM working to develop risk-adjusted, international benchmarks on health outcomes by medical condition.

Adaptive Design: The Faster Path to Market

An adaptive design clinical trial can help to create a stronger value proposition for your medical device by reducing development costs and accelerating time-to-market.

Oncology: Identifying & Reducing Barriers at the Site Level

Specific ideas and innovative approaches that can make a real difference to the successful conduct of industry-sponsored oncology clinical trials.